
Nyczon SB 1000mg/500mg Injection
Marketer
Cassopeia Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Nyczon SB 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby controlling infection spread. Administration must be under a physician's direct guidance. Adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, even with symptom improvement, as premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress) require prompt emergency care. Prior to commencing treatment, inform your doctor of any existing medications or health conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your physician may order laboratory tests to monitor treatment response.
Uses of Nyczon SB 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Nyczon SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nyczon SB 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nyczon SB 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Nyczon SB 1000mg/500mg Injection works:
The injectable formulation Nyczon SB (1000mg Ceftriaxone/500mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their viability. Sulbactam, by countering bacterial resistance mechanisms, potentiates Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Nyczon SB 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Nyczon SB 1000mg/500mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Nyczon SB 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Nyczon SB 1000mg/500mg Injection could lead to reduced awareness, impaired vision, drowsiness, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Nyczon SB 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The 1000mg/500mg Nyczon SB Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for the 1000mg/500mg Nyczon SB Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Nyczon SB 1000mg/500mg Injection :
Should you forget a scheduled dose of Nyczon SB 1000mg/500mg Injection, seek advice from your physician.
Facts to Know About Nyczon SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
